BOLT - Bolt Biotherapeutics GAAP EPS of -$0.28 revenue of $5.3M May, 15 2024 10:19 AM Bolt Biotherapeutics Inc. 2024-05-15 10:19:00 ET More on Bolt Biotherapeutics Bolt Biotherapeutics draws downgrades after portfolio shakeup Seeking Alpha’s Quant Rating on Bolt Biotherapeutics Historical earnings data for Bolt Biotherapeutics Financial information for Bolt Biotherapeutics For further details see: Bolt Biotherapeutics GAAP EPS of -$0.28, revenue of $5.3M